The DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
The Possibility of Systematic Research Fraud Targeting Under-Studied Human Genes: Causes, Consequences, and Potential Solutions
Open accessAbstract
A major reason for biomarker failure is the selection of candidate biomarkers based on inaccurate or incorrect published results. Incorrect research results leading to the selection of unproductive biomarker candidates are largely considered to stem from unintentional research errors. The additional possibility that biomarker research may be actively misdirected by research fraud has been given comparatively little consideration. This review discusses what we believe to be a new threat to biomarker research, namely, the possible systematic production of fraudulent gene knockdown studies that target under-studied human genes. We describe how fraudulent papers may be produced in series by paper mills using what we have described as a ‘theme and variations’ model, which could also be considered a form of salami slicing. We describe features of these single-gene knockdown publications that may allow them to evade detection by journal editors, peer reviewers, and readers. We then propose a number of approaches to facilitate their detection, including improved awareness of the features of publications constructed in series, broader requirements to post submitted manuscripts to preprint servers, and the use of semi-automated literature screening tools. These approaches may collectively improve the detection of fraudulent studies that might otherwise impede future biomarker research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Experiments that analyse individual genes typically require nucleotide sequence reagents as either targeting and/or control reagents (8, 11).”
From Identification of human gene research articles with wrongly identified nucleotide sequences (2022) · cites this paper as [8]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“We have proposed that nucleotide sequences may be particularly prone to error, as they can be affected by different error types that are very challenging to detect by eye (8, 11, 12).”
From Identification of human gene research articles with wrongly identified nucleotide sequences (2022) · cites this paper as [8]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As such, wrongly identified sequences are likely to represent unintended hidden errors that persist when sequence identities are not actively checked during manuscript preparation or review (8, 11, 12).”
From Identification of human gene research articles with wrongly identified nucleotide sequences (2022) · cites this paper as [8]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Whereas genuine gene research requires time, expertise, and material resources, the mass production of fraudulent gene research articles by paper mills could be quicker and cheaper by orders of magnitude (8).”
From Identification of human gene research articles with wrongly identified nucleotide sequences (2022) · cites this paper as [8]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“because genuine pre-clinical gene research requires specialised expertise, time, and material resources (13), the mass production of fraudulent gene research articles could be quicker and cheaper by orders of magnitude (8).”
From Identification of human gene research articles with wrongly identified nucleotide sequences (2022) · cites this paper as [8]
Experimental — accuracy not yet measured
27 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
19 retracted
Retraction note to multiple articles in Tumor Biology
Stigbrand, T. (2017) · Tumor Biology · doi:10.1007/s13277-017-5487-6 · Cited by 57
RetractedWang, L., Zhang, Y., Lv, W., Lu, J., Mu, J., Liu, Y., & Dong, P. (2015) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12573 · Cited by 21
RetractedHuang, W., Chen, D., Li, N., & Wang, L. (2017) · PubMed Central · doi:10.22034/apjcp.2017.18.10.2891 · Cited by 20
RetractedLi, Y.-L., Gao, Y., Xu, Y., Sun, X., Song, X., Ma, H., & Yang, M. (2014) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12428 · Cited by 17
RetractedRetracted: Tumor Protein D52-Like 2 Contributes to Proliferation of Breast Cancer Cells
Yang, M., Wang, X., Jia, J., Gao, H., Chen, P., Sha, X., & Wu, S. (2015) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2014.1723 · Cited by 13
RetractedHe, Y., Chen, F., Cai, Y., & Chen, S. (2016) · Cell Biology International · doi:10.1002/cbin.10593 · Cited by 8
RetractedRetracted: Tumor Protein D52-Like 2 Accelerates Gastric Cancer Cell Proliferation In Vitro
Xu, J., Wang, W., Zhu, Z., Wei, Z., Yang, D., & Cai, Q. (2015) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2014.1766 · Cited by 7
RetractedQi, Y., Hu, T., Li, K., Ye, R., & Ye, Z. (2015) · Journal of Breast Cancer · doi:10.4048/jbc.2015.18.3.218 · Cited by 6
RetractedSUN1 silencing inhibits cell growth through G0/G1 phase arrest in lung adenocarcinoma
Huang, W., Huang, H., Wang, L., Hu, J., & Song, W. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s79727 · Cited by 4
RetractedRetraction – Down-regulation of GPR137 expression inhibits proliferation of colon cancer cells
Zhang, K., Shen, Z., Liang, X., Liu, T., Wang, T., & Jiang, Y. Z. (2018) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmy057 · Cited by 4
Retracted
Research works printed but not linked: 12
- Retraction, 2016, Int J Clin Exp Med, 9, 12416
- Wang Z, 2014, Cell Mol Biol (Noisy-le-grand), 60, 39
- 10.1016/S0022-2836(05)80360-2 · doi:10.1016/s0022-2836(05)80360-2 · Paper page
- Huang WY, 2017, Asian Pac J Cancer Prev, 18, 2891
- 2017, Biomed Res Int, 2017, 3471417
- 2018, Int J Clin Exp Med, 11, 2917
- 2018, Int J Clin Exp Pathol, 11, 1838
- 2018, Int J Clin Exp Pathol, 11, 1836
- 2017, Asian Pac J Cancer Prev, 18, 2893
- 2017, Biomed Res Int, 2017, 7640820
- 2018, Int J Clin Exp Med, 11, 413
- Acuna DE, 2018, bioRxiv, 269415
Cited by
AI for life: Trends in artificial intelligence for biotechnology
Holzinger, A., Keiblinger, K., Holub, P., Zatloukal, K., & Müller, H. (2023) · New Biotechnology · doi:10.1016/j.nbt.2023.02.001 · Cited by 438
Byrne, J. A., & Christopher, J. (2020) · FEBS Letters · doi:10.1002/1873-3468.13747 · Cited by 133
Self-citationChina bans cash rewards for publishing papers
Mallapaty, S. (2020) · Nature · doi:10.1038/d41586-020-00574-8 · Cited by 100
The raw truth about paper mills
Christopher, J. (2021) · FEBS Letters · doi:10.1002/1873-3468.14143 · Cited by 99
“1754 FEBS Letters 595 (2021) 1751–1757 a 2021 Federation of European Biochemical Societies The Scientists’ Forum”
BackgroundInfluentialThe landscape of biomedical research
González-Márquez, R., Schmidt, L., Schmidt, B. M., Berens, P., & Kobak, D. (2024) · Patterns · doi:10.1016/j.patter.2024.100968 · Cited by 89
Data integrity of 35 randomised controlled trials in women' health
Bordewijk, E. M., Wang, R., Askie, L. M., Gurrin, L. C., Thornton, J. G., van Wely, M., Li, W., & Mol, B. W. (2020) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2020.04.016 · Cited by 66
Byrne, J. A., Park, Y., Richardson, R. A. K., Pathmendra, P., Sun, M., & Stoeger, T. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac1139 · Cited by 46
“Targeted human gene research provides several scaling factors that could enable the production of many individual manuscripts (10,27,56) (Figure 4).”
InfluentialSelf-citationA call for research to address the threat of paper mills
Byrne, J. A., Abalkina, A., Akinduro-Aje, O., Christopher, J., Eaton, S. E., Joshi, N., Scheffler, U., Wise, N. H., & Wright, J. (2024) · PLoS Biology · doi:10.1371/journal.pbio.3002931 · Cited by 39
Self-citationIdentification of human gene research articles with wrongly identified nucleotide sequences
Park, Y., West, R. A., Pathmendra, P., Favier, B., Stoeger, T., Capes-Davis, A., Cabanac, G., Labbé, C., & Byrne, J. A. (2022) · Life Science Alliance · doi:10.26508/lsa.202101203 · Cited by 37
“error, as they can be affected by different error types that are very challenging to detect by eye (8, 11, 12).”
InfluentialSelf-citationCOVID-19 research risks ignoring important host genes due to pre-established research patterns
Stoeger, T., & Nunes Amaral, L. A. (2020) · eLife · doi:10.7554/elife.61981 · Cited by 30
“Lastly, concerns have been expressed about the possibility that fraudulent gene knockdown studies that target under-studied human genes may be corrupting the literature and impeding research into biomarkers (Byrne et al., 2019).”
BackgroundWittau, J., & Seifert, R. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03272-8 · Cited by 36
Scancar, B., Byrne, J. A., Causeur, D., & Barnett, A. G. (2026) · BMJ · doi:10.1136/bmj-2025-087581 · Cited by 38
Self-citationLightweight Distributed Provenance Model for Complex Real–world Environments
Wittner, R., Mascia, C., Gallo, M., Frexia, F., Müller, H., Plass, M., Geiger, J., & Holub, P. (2022) · Scientific Data · doi:10.1038/s41597-022-01537-6 · Cited by 27
Byrne, J. A., Park, Y., West, R. A., Capes-Davis, A., Favier, B., Cabanac, G., & Labbé, C. (2021) · Scientometrics · doi:10.1007/s11192-021-03871-9 · Cited by 21
Self-citationDelmas, M., Filangi, O., Paulhe, N., Vinson, F., Dupérier, C., Garrier, W., Saunier, P.-E., Pitarch, Y., Jourdan, F., Giacomoni, F., et al. (2021) · Bioinformatics · doi:10.1093/bioinformatics/btab627 · Cited by 26
“For example, one particular harmful practice consisting of multiplying articles from single experiments, coined ”salamislicing” [45, 46, 47], may pass peer-review and evade retractation, while still inducing bias in the contingency table and thus potentially yield spurious associations.”
BackgroundToward a common standard for data and specimen provenance in life sciences
Wittner, R., Holub, P., Mascia, C., Frexia, F., Müller, H., Plass, M., Allocca, C. M., Betsou, F., Burdett, T., Cancio, I., et al. (2023) · Learning Health Systems · doi:10.1002/lrh2.10365 · Cited by 30
“of the control mechanisms that traditionally ensured the quality of data and processes.(1-11) At the same time, the origin and history of”
BackgroundOrtega, J. L. (2020) · Learned Publishing · doi:10.1002/leap.1339 · Cited by 18
Tracing open data in emergencies: The case of the COVID‐19 pandemic
Gkiouras, K., Nigdelis, M. P., Grammatikopoulou, M. G., & Goulis, D. G. (2020) · European Journal of Clinical Investigation · doi:10.1111/eci.13323 · Cited by 20
Distortion of journal impact factors in the era of paper mills
Bricker-Anthony, C., & Herzog, R. W. (2023) · Molecular Therapy · doi:10.1016/j.ymthe.2023.05.008 · Cited by 16
van Diest, R. A., Seifert, R., & van der Heyden, M. A. G. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03697-1 · Cited by 15
Pathmendra, P., Park, Y., Enguita, F. J., & Byrne, J. A. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02846-2 · Cited by 14
“The rapid production of many gene research manuscripts at minimal cost could provide limited time for quality control, which could result in errors such as wrongly identified nucleotide sequence reagents (Byrne and Labbé 2017; Byrne et al. 2019).”
BackgroundInfluentialSelf-citationThe 1-h fraud detection challenge
van der Heyden, M. A. G. (2021) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-021-02120-3 · Cited by 13
Nazarovets, S. (2024) · Springer eBooks · doi:10.1007/978-981-97-4060-4_14 · Cited by 11
Issues and Challenges to Reproducibility of Cancer Research: A Commentary
da Silva, J. A. T. (2022) · Future Oncology · doi:10.2217/fon-2021-1378 · Cited by 9
A new chapter for a better Bioscience Reports
Cooper, C. D. O., & Han, W. (2021) · Bioscience Reports · doi:10.1042/bsr20211016 · Cited by 6
Combatting the rise of paper mills
Calver, M. (2021) · Pacific Conservation Biology · doi:10.1071/pcv27n1_ed · Cited by 6
Revues prédatrices et paper mills mettent en péril la gestion des savoirs
Maisonneuve, H. (2024) · Bulletin du Cancer · doi:10.1016/j.bulcan.2024.12.002 · Cited by 8
Prevalence of Problematic Papers in Non-Coding RNA Research
Lou, Y., Zhou, Z., Shen, Z., & Li, M. (2024) · doi:10.1101/2024.08.28.607530 · Cited by 3
Suspected distortion of citations in high-impact cancer journals
Scancar, B., Byrne, J. A., Causeur, D., & Barnett, A. G. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2618402123 · Cited by 3
Self-citationLarge-scale falsification of research papers risks public trust in biomedical sciences
Bricker-Anthony, C., & Herzog, R. W. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.03.015 · Cited by 2
Spiridion Kanellis, un plagiaire audacieux du XIXesiècle
Gautron, L. (2020) · Biologie Aujourd hui · doi:10.1051/jbio/2020009
“Malheureusement, la situation n ’ a fait que s ’ aggraver avec l ’ émergence de véritables « usines à articles » publiant de faux articles et des plagiats académiques à grande échelle (Byrne et al. , 2019).”
BackgroundRedman, B. K. (2023) · Collaborative bioethics · doi:10.1007/978-3-031-29455-6_2
Membangun Integritas Ilmiah Melalui Webinar Fraud dalam Akademik dan Penelitian
Julialevi, K. O., Basid, A., Rahayu, N., Saputra, R. S., Zarkasyi, W., Winarningsih, S., & Sukmadilaga, C. (2026) · ADMA Jurnal Pengabdian dan Pemberdayaan Masyarakat · doi:10.30812/adma.v6i2.5141
“Research fraud merupakan pelanggaran etika yang disengaja dan dapat merusak integritas dunia akademik serta kepercayaan publik terhadap ilmu pengetahuan (Byrne et al., 2019).”
InfluentialThe landscape of problematic papers in the field of non-coding RNA
Lou, Y., Zhou, Z., Wang, G., Shen, Z., & Li, M. (2026) · Journal of Informetrics · doi:10.1016/j.joi.2026.101851 · Cited by 1
“Active research is ongoing to reveal the yet undiscovered functions of ncRNAs [4], resulting in a surge of publications in the field of ncRNA [32, 18].”
InfluentialPaper mills in dermatology: a cross-sectional study of retracted publications
Tan, E., Epstein, R. J., Ahmed, S., & Williams, H. C. (2026) · British Journal of Dermatology · doi:10.1093/bjd/ljag381
Metadata
- Authors
- Byrne, J. A., Grima, N., Capes-Davis, A., & Labbé, C.
- Affiliations
- The University of Sydney (AU)
- CellBank Australia, Children’s Medical Research Institute and The University of Sydney, Westmead, NSW, Australia
- Institut polytechnique de Grenoble (FR)
- Corresponding author
- Byrne, Jennifer A
- Venue
- Biomarker Insights
- Publisher
- SAGE Publications
- Published
- 2019-01
- Volume
- 14
- Pages
- 1177271919829162-1177271919829162
- ISSN
- 1177-2719 (ISSN-L)
- PMC
- PMC6366001
- OpenAlex
- W2914992144
- Cited by
- 34
- References
- 95
- Citations by year
- 2026: 4 · 2025: 1 · 2024: 8 · 2023: 4 · 2022: 4 · 2021: 6 · 2020: 7
- FWCI
- 1.12
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Biomarker Insights (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Post-Truth Initiative (SREI 2020)
- US Office of Research Integrity Project Grant (ORIIR180038-01-00)
- Topics
- Social Sciences › Education › Academic integrity and plagiarism
- Social Sciences › Library and Information Sciences › Academic Publishing and Open Access
- Physical Sciences › Mathematics › Statistics and Probability › Benford’s Law and Fraud Detection
- Keywords
- scientific fraud, paper mills, salami slicing, fraud detection, preprint servers, peer review
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.